ALFA Filings
Every announcement, straight from the exchange
Every Eris Lifesciences debt & borrowing announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Eris Lifesciences Limited submitted its half-yearly reporting of debt securities for the period ended September 30, 2026. Two tranches of NCDs totaling ₹1,250 Crore remain outstanding.
Eris Lifesciences has entered into a term loan agreement with Axis Bank Limited for ₹45 Crore to meet general liabilities.
Eris Lifesciences Limited has drawn down a ₹64.40 Crore working capital term loan from Axis Bank. The funds will be used to meet existing short-term liabilities.
Eris Lifesciences paid ₹109.12 Crore in gross interest for two NCD series. This routine debt servicing confirms the company's ability to meet its ongoing financial obligations.
Eris Lifesciences fixed May 24, 2026, as the record date for NCD interest payments. Payments for two ISINs are scheduled for June 8, 2026.